you are here: HomeNewsNr munjal
nr munjal
Jump to
4 Results Found
  • Ind Swift Labs gets USFDA nod for two more DMFs Mar 23, 2011 07:07 PM IST

    Ind Swift Labs gets USFDA nod for two more DMFs

    Pharma major Ind-Swift Laboratories Ltd, which has a strong basket of over 40 products across 16 therapeutic segments, has got the USFDA nod for two more DMFs Temozolomide and Telmisartan. Besides commercially supplying four molecules to the US, the company has hitherto filed 20 DMFs with the USFDA, of which all have been approved.

  • How Indian pharma SMEs can capture the global market Mar 09, 2011 11:35 AM IST

    How Indian pharma SMEs can capture the global market

    CNBC-TV18 special series for small and medium enterprises 'SME CEO Knowledge Series' discusses the strengths of the SME sector and the opportunities available to them to get them to a global stage.

  • Pharma firms want tax cuts, R&D sops boost Feb 28, 2011 07:14 AM IST

    Pharma firms want tax cuts, R&D sops boost

    Drugmakers want tax exemption deadline for export oriented unit (EOUs) to be extended and want infrastructure or priority sector status in the budget on Feb 28.

  • India drug transport cost may fall 15%-20% if dispute ends Jan 07, 2011 04:08 PM IST

    India drug transport cost may fall 15%-20% if dispute ends

    The transportation costs of Indian drug firms is expected to fall by 15% to 20% percent once a dispute between India and Europe over drug shipments is resolved, NR Munjal, president, Indian Drug Manufacturers' Association, told Reuters.

Sections